This is the most consequential piece of law in the sector and it is short enough to understand completely. Most of the confusion around it comes from mixing up two separate layers: what the medicines legislation requires, and what professional standards require.
The classification
A prescription only medicine may be supplied only in accordance with a prescription given by an appropriate practitioner. Botulinum toxin products fall into that class. There is no general clinic authority, standing arrangement or bulk supply mechanism that removes the need for an individual prescription in this setting.
Most dermal fillers, by contrast, are regulated as medical devices rather than as medicines. That is a different framework with different requirements, and the two are constantly conflated in marketing. Whether a product is a medicine or a device is the first thing to establish about it.
Who may prescribe
Prescribing is restricted to appropriate practitioners: doctors and dentists, and appropriately qualified independent prescribers among nurses, pharmacists and certain other professions. Independent prescriber status is recorded as an annotation on the relevant professional register and can be checked by anyone in a few minutes.
Nothing in the medicines legislation requires the prescriber to be the person who administers the medicine. That is worth stating clearly because it is where most of the sector's grey area lives.
The personal assessment requirement, and where it comes from
The requirement that a prescriber assess the patient themselves does not come from the medicines regulations. It comes from professional standards. The General Medical Council's prescribing guidance addresses injectable cosmetic medicines specifically and sets out that the prescriber should carry out a physical examination of the patient rather than prescribing remotely. Other prescribing professions are subject to equivalent standards from their own regulators.
The distinction matters enormously in practice. An arrangement can sit within the letter of the medicines framework while the prescriber attached to it is in breach of their own regulator's standards. Only one party in that arrangement has a registration at stake, and it is not usually the person injecting.
ObservedThe GMC's prescribing guidance addresses injectable cosmetic medicines and is published in full. It is the primary source for this and is worth reading rather than summarising.AnalysisThe gap between the statutory floor and the professional standard is the structural fault line in UK injectable aesthetics. Almost every periodic scandal in this sector resolves into it.If you are assessing an arrangement, the four facts that settle it are: who prescribed, what their registration and annotation are, when they assessed the patient, and how. A name, a number, a date and a method. Anything shorter than those four is a script rather than an answer.
The advertising prohibition
Advertising a prescription only medicine to the general public is prohibited. That prohibition is broad and is not limited to paid advertising in the conventional sense: a clinic's own website, its social posts and material published on its behalf are all capable of being caught.
The CAP Code contains a corresponding rule, and the Advertising Standards Authority is the mechanism most operators actually encounter, with the MHRA holding the statutory role. Abbreviations, deliberate misspellings, hashtags and symbol substitution do not change the analysis, because the question is whether the material promotes the medicine to the public.
This is the single most frequently breached rule in the sector, and the durable cost of breach is not the sanction but the published ruling, which remains indexed, searchable and quotable indefinitely.
Why compliance is commercially uncomfortable
Compliant prescribing is a scheduling constraint before it is a money cost. If the prescriber must assess in person, the prescriber's availability becomes a limit on the clinic's throughput, and throughput is where the economics of a small clinic live.
Three responses exist and all three are visible in the market: employ or partner with a prescriber and absorb the cost; become a prescriber, which explains much of the sector's appetite for prescribing qualifications among nurses and pharmacists; or arrange prescribing at arm's length and hope nobody asks. The second route both removes the constraint and improves the compliance position, and it raises the barrier to entry for everyone else, which is a market structure effect nobody legislated for.
Supply, storage and the paperwork nobody checks
The prescription is only the first document. A prescription only medicine has to be obtained through a lawful supply chain, stored correctly according to the product's requirements, administered to the named patient it was prescribed for, and recorded.
Each of those creates a paper trail, and each is a question that can be asked afterwards. Where was the product obtained from. Was it stored within the specified conditions and is that recorded. Was it administered to the patient named on the prescription. What batch was used, and is that recorded against that patient's record.
The batch question is the one that matters most in a complication. Without a batch record, a product related problem cannot be traced, cannot be reported usefully to the MHRA, and cannot be investigated at all. It costs nothing to record and it is recorded far less consistently than it should be.
The chain, and where it breaks
Set out in order, the chain is: a prescriber assesses the patient personally; the prescriber writes a prescription for that named patient; the product is obtained lawfully against that prescription; it is stored correctly; it is administered to that patient by a competent person; and the whole thing is recorded.
Ask which link is weakest in any given arrangement and the answer is almost always the first. Everything downstream can be documented retrospectively and often is. Whether a prescriber genuinely assessed a patient before writing for them is the one link that cannot be reconstructed afterwards, which is precisely why it is the link the professional standards address directly and the one that generates the sector's periodic scandals.
How to verify any of it
Ask for the prescriber's full registered name and registration number. Search the relevant professional regulator's public register, free of charge, and confirm both registration and the independent prescriber annotation where the prescriber is not a doctor or dentist. Ask when and how the assessment took place.
If the answer to the last question is that a form was completed or a photograph was reviewed, that is a remote prescribing arrangement, and it is the thing the professional standards address directly.